International Association for the Study of Lung Cancer (IASLC) shared on LinkedIn:
“Effective policy has the power to improve lung cancer outcomes, but meaningful change requires informed advocacy.
The new IASLC Global Lung Cancer Policy Engagement Toolkit provides advocates, clinicians, researchers, patient organizations, and other stakeholders with practical resources to engage policymakers and advance evidence-based improvements in lung cancer prevention, early detection, treatment, and survivorship.
Developed by the IASLC Global Policy and Partnerships Committee, the toolkit includes:
- Key policy messages
- Downloadable factsheets
- Advocacy guidance
- Ready-to-use communications resources
Whether you’re advocating at the local, national, or global level, these tools can help strengthen your efforts and drive meaningful policy change.”
Download the toolkit.
You might be interested in:
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
